Frankfurt - Delayed Quote EUR
Apellis Pharmaceuticals, Inc. (1JK.F)
15.14
+0.54
+(3.73%)
As of 8:08:11 AM GMT+2. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 17.38M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| WHEELER CRAIG A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 17, 2025 |
| CHOPAS JAMES GEORGE Officer | Sale at price 24.82 per share. | Direct | 4,543 | Mar 17, 2025 |
| WATSON DAVID O General Counsel | Sale at price 25.10 per share. | Direct | 139,789 | Mar 5, 2025 |
| WATSON DAVID O General Counsel | Stock Gift at price 0.00 per share. | Indirect | 0 | Mar 4, 2025 |
| DELONG MARK JEFFREY Officer | Sale at price 28.54 per share. | Direct | 10,360 | Feb 11, 2025 |
| SULLIVAN TIMOTHY EUGENE Chief Financial Officer | Sale at price 29.52 per share. | Direct | 16,120 | Jan 29, 2025 |
| FRANCOIS CEDRIC G Chief Executive Officer | Sale at price 29.52 per share. | Direct | 83,375 | Jan 29, 2025 |
| WATSON DAVID O General Counsel | Sale at price 29.52 per share. | Direct | 20,519 | Jan 29, 2025 |
| NICHOLSON NUR Chief Technology Officer | Sale at price 29.52 per share. | Direct | 24,357 | Jan 29, 2025 |
| DELONG MARK JEFFREY Officer | Sale at price 29.52 per share. | Direct | 10,776 | Jan 29, 2025 |
| DESCHATELETS PASCAL Officer | Sale at price 29.52 per share. | Direct | 24,386 | Jan 29, 2025 |
| TOWNSEND ADAM J Officer | Sale at price 29.52 per share. | Direct | 20,519 | Jan 29, 2025 |
| LEWIS KAREN Officer | Sale at price 29.52 per share. | Direct | 10,747 | Jan 29, 2025 |
| EISELE JEFFREY Officer | Sale at price 29.52 per share. | Direct | 8,208 | Jan 29, 2025 |
| SULLIVAN TIMOTHY EUGENE Chief Financial Officer | Sale at price 30.43 per share. | Direct | 93,954 | Jan 22, 2025 |
| FRANCOIS CEDRIC G Chief Executive Officer | Sale at price 30.43 per share. | Direct | 412,296 | Jan 22, 2025 |
| WATSON DAVID O General Counsel | Sale at price 30.43 per share. | Direct | 101,104 | Jan 22, 2025 |
| NICHOLSON NUR Chief Technology Officer | Sale at price 30.43 per share. | Direct | 120,120 | Jan 22, 2025 |
| CHOPAS JAMES GEORGE Officer | Sale at price 30.43 per share. | Direct | 33,346 | Jan 22, 2025 |
| DELONG MARK JEFFREY Officer | Sale at price 30.43 per share. | Direct | 42,474 | Jan 22, 2025 |
| DESCHATELETS PASCAL Officer | Sale at price 30.43 per share. | Direct | 120,120 | Jan 22, 2025 |
| TOWNSEND ADAM J Officer | Sale at price 30.43 per share. | Direct | 101,104 | Jan 22, 2025 |
| LEWIS KAREN Officer | Sale at price 30.43 per share. | Direct | 53,275 | Jan 22, 2025 |
| EISELE JEFFREY Officer | Sale at price 30.43 per share. | Direct | 39,279 | Jan 22, 2025 |
| WATSON DAVID O General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 21, 2025 |
| DESCHATELETS PASCAL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 21, 2025 |
| LEWIS KAREN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 21, 2025 |
| NICHOLSON NUR Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 21, 2025 |
| CHOPAS JAMES GEORGE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 21, 2025 |
| DELONG MARK JEFFREY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 21, 2025 |
| BAUMAL CAROLINE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 21, 2025 |
| SULLIVAN TIMOTHY EUGENE Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 21, 2025 |
| FRANCOIS CEDRIC G Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 21, 2025 |
| SULLIVAN TIMOTHY EUGENE Chief Financial Officer | Sale at price 29.96 per share. | Direct | 51,828 | Jan 17, 2025 |
| FRANCOIS CEDRIC G Chief Executive Officer | Sale at price 29.96 per share. | Direct | 179,959 | Jan 17, 2025 |
| WATSON DAVID O General Counsel | Sale at price 29.96 per share. | Direct | 65,938 | Jan 17, 2025 |
| CHOPAS JAMES GEORGE Officer | Sale at price 29.96 per share. | Direct | 21,420 | Jan 17, 2025 |
| DELONG MARK JEFFREY Officer | Sale at price 29.96 per share. | Direct | 36,998 | Jan 17, 2025 |
| BAUMAL CAROLINE Officer | Sale at price 29.96 per share. | Direct | 55,513 | Jan 17, 2025 |
| DESCHATELETS PASCAL Officer | Sale at price 29.96 per share. | Direct | 22,469 | Jan 17, 2025 |
| TOWNSEND ADAM J Officer | Sale at price 29.96 per share. | Direct | 65,938 | Jan 17, 2025 |
| LEWIS KAREN Officer | Sale at price 29.96 per share. | Direct | 37,178 | Jan 17, 2025 |
| NICHOLSON NUR Chief Technology Officer | Sale at price 29.96 per share. | Direct | 64,260 | Jan 17, 2025 |
| SULLIVAN TIMOTHY EUGENE Chief Financial Officer | Sale at price 28.70 per share. | Direct | 62,284 | Jan 13, 2025 |
| FRANCOIS CEDRIC G Chief Executive Officer | Sale at price 28.70 per share. | Direct | 179,302 | Jan 13, 2025 |
| WATSON DAVID O General Counsel | Sale at price 28.70 per share. | Direct | 142,506 | Jan 13, 2025 |
| CHOPAS JAMES GEORGE Officer | Sale at price 28.70 per share. | Direct | 22,474 | Jan 13, 2025 |
| DELONG MARK JEFFREY Officer | Sale at price 28.70 per share. | Direct | 45,895 | Jan 13, 2025 |
| DESCHATELETS PASCAL Officer | Sale at price 28.70 per share. | Direct | 65,670 | Jan 13, 2025 |
| TOWNSEND ADAM J Officer | Sale at price 28.70 per share. | Direct | 77,065 | Jan 13, 2025 |
Related Tickers
AVU0.F Adverum Biotechnologies, Inc.
2.5000
-0.79%
1T3.F Syndax Pharmaceuticals, Inc.
11.50
+0.88%
F6T.F Fate Therapeutics, Inc.
1.0760
-2.09%
THRD Third Harmonic Bio, Inc.
5.16
+0.19%
SION Sionna Therapeutics, Inc.
12.03
-0.08%
UPB Upstream Bio, Inc.
9.03
+2.79%
FULC Fulcrum Therapeutics, Inc.
3.7007
+3.66%
TENX Tenax Therapeutics, Inc.
5.81
-1.19%
KYTX Kyverna Therapeutics, Inc.
2.0600
+0.49%
BDRX Biodexa Pharmaceuticals Plc
1.4900
-1.97%